Related Experiment Videos
Pediatric osteosarcoma: a 35-year experience in Slovenia
1Clinical Radiology Institute, University Medical Center Ljubljana, 1525 Ljubljana, Slovenia. dimitrij.kuhelj@guest.arnes.si
Pediatric Hematology and Oncology
|July 16, 2005
Summary
This study reviewed osteosarcoma treatment in Slovenian children and adolescents, finding a 48% survival rate. Chemotherapy and disease stage significantly impact survival, highlighting the need for new therapeutic strategies.
Area of Science:
- Pediatric Oncology
- Skeletal Oncology
- Medical Imaging
Background:
- Osteosarcoma is a primary bone cancer affecting children and adolescents.
- Long-term survival rates for osteosarcoma have historically been a challenge.
- Effective classification and prognostic factors are crucial for treatment planning.
Purpose of the Study:
- To review pediatric and adolescent osteosarcoma cases in Slovenia from 1968-1997.
- To evaluate a newly devised classification system for osteosarcoma.
- To identify prognostic factors influencing survival in young osteosarcoma patients.
Main Methods:
- Retrospective analysis of 74 patients diagnosed with osteosarcoma.
- Classification of patients using a novel system based on clinical and imaging data.
- Statistical analysis to determine prognostic factors affecting survival.
Main Results:
- Overall survival rate for the cohort was 48%.
- Disease stage at diagnosis and specific treatments, including chemotherapy, were significant prognostic factors.
- The newly developed classification system demonstrated adequacy in categorizing patients.
Conclusions:
- Chemotherapy has improved osteosarcoma survival rates in pediatric and adolescent populations.
- Further research into novel therapeutic strategies is warranted for various disease stages.
- The proposed clinical and imaging-based classification system is a valuable tool for osteosarcoma management.